Effectiveness and Safety of Treatment of Double Chin with Combined Enzymatic Therapy
DOI:
https://doi.org/10.34257/LJMHR225763UKKeywords:
collagenase, combined enzymatic treatment, double chin, hyaluronic acid, lipase, lyaseAbstract
Cellulite is a common aesthetic concern that may significantly impact on individuals’ self-image and quality of life. Despite being a non-threatening condition, it may have a negative effect on the psychological well-being of affected individuals. This condition is multifactorial and involves several physiopathology pathways. The role of enzymes in the management of cellulite is a novel approach, particularly lipase and collagenase, which play key roles in adipocyte size reduction and collagen degradation, respectively. The potential of high-molecular-weight hyaluronic acid to promote tissue repair and regeneration is also highlighted. Our case report describes the effectiveness of an association of recombinant enzymes and high-molecular-weight hyaluronic acid by reducing cellulite manifestations in a patient, with a history of multiple unsuccessful treatments, showing visible improvements from the initial treatment session. The importance of understanding the complex physiopathology of cellulite and choosing a targeted approach is emphasized.
References
H Leal-Silva, E Carmona-Hernández, N López-Sánchez (2016) Reducción de grasa subcutánea, técnicas invasivas y no invasivas. 60, 129-41.
B Ascher, J Fellmann, G Monheit (2016) ATX-101 (deoxycholic acid injection) for reduction of submental fat. 1131-43.
L Baumann, S M Shridharani, S Humphrey, C J Gallagher (2019) Personal (Self) Perceptions of Submental Fat Among Adults in the United States. 45(1), 124-130.
K S Cunha, F Lima, R M Cardoso (2021) Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials. 383-97.
T Fattahi (2012) Submental liposuction versus formal cervicoplasty: which one to choose?. 70, 2854-8.
R W Brobst, M Ferguson, S W Perkins (2014) Noninvasive treatment of the neck. 22, 191-202.
M Vellard (2003) The enzyme as drug: application of enzymes as pharmaceuticals. 14, 444-50.
K Kishore, P Krishan (2009) Pharmacology of recombinant or genetically engineered drugs. 1, 141.
K Walker, B M Basehore, A Goyal (2025) Hyaluronic Acid. https://www.ncbi.nlm.nih.gov/books/NBK482440/
B S Sekhon (2010) Matrix metalloproteinases – an overview. ((1)), 1-20.
F Jimenez-Acosta, L Planas, N S Penneys (1990) Lipase expression in human skin. 1(3), 195-200.
G C Weber, B A Buhren, H Schrumpf, J Wohlrab, P A Gerber (2019) Clinical Applications of Hyaluronidase. 1148, 255-77.
H Jung (2020) Hyaluronidase: An overview of its properties, applications, and side effects. 47(4), 297.
R Jabbour, F Farah, F Mallat, E Saad, K Semaan, R Haber, J Helou (2024) Efficacy and safety of the enzymatic mixture - Lipase, collagenase and hyaluronidase - In the treatment of moderate to severe submental fat: A prospective cohort study. e25759.
I López Gehrke, A E Soto Montenegro, E Santaella, Y Prada Castellanos, J López Berroa (2024) Grado de satisfacción de pacientes tratados estéticamente con enzimas recombinantes; experiencia clínica. 6, 47-55.
Shadfar S, Perkins SW (2014) Anatomy and physiology of the aging neck. 22, 161-70.
S Choo, G Marti, M Nastai, J Mallalieu, M Shermak (2010) Biomechanical properties of skin in massive weight loss patients. 20(10), 1422–1428.
P Björntorp (1997) Hormonal control of regional fat distribution. 12((Suppl 1)), 21-5.
J R Montes, E Santos, A Chillar (2020) Jowl Reduction with Deoxycholic Acid. 46, 78-85.
A N Boca, I López-Gehrke, C Lloreda, S Rustamzada, J A López-Berroa (2024) Recombinant enzymatic products in Dermatology. 16, e20240306.
F Chen, G Du, M Shih, H Yuan, P Bao, S Shi (2019) Safe and effective subcutaneous adipolysis in minipigs by a collagenase derivative. 14(12), e0227202.
H Van Wart, N Rawlings (2013) Handbook of Proteolytic Enzymes. 607-11.
T Dokoshi, L juan Zhang, T Nakatsuji, C A Adase, J A Sanford, R D Paladini (2023) Hyaluronidase inhibits reactive adipogenesis and inflammation of colon and skin. 3((21)), e123072.
T D Dobbs, S Hughes, N Mowbray, H A Hutchings, I S Whitaker (2018) How to decide which patient-reported outcome measure to use? A practical guide for plastic surgeons. 71, 957-66.
S Rauch, P De Simone, V Bertucci (2024) Applicability of Patient-Reported Outcome Measures to Aesthetic Medicine Patient Archetypes. 50((1)), 86-92.
S Y Park, S B Kim, J Wan, F Felice, K H Yi (2024) Lipolytic agents for submental fat reduction. 30((2)), e13601.
R Abdi Dezfouli, A Hosseinpour, M Qorbani, E Daneshzad (2023) The efficacy of topical aminophylline in local fat reduction: a systematic review. 14, 1087614.
S M Hoefflin (2002) Lipoplasty with hypotonic pharmacologic lipo-dissolution. 22((6)), 1321-1324.
G W Kim, S H Chung (2021) The beneficial effect of glycerophosphocholine to local fat accumulation: a comparative study with phosphatidylcholine and aminophylline. 25((4)), 333-339.
M K Caruso, A T Roberts, L Bissoon, K S Self, T S Guillot, F L Greenway (2008) An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite. 61((11)), 1321-1324.
D H Jones, J Carruthers, J H Joseph, V D Callender, P Walker, D R Lee, et al. (2016) REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction. 42, 38-49.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.
